Bacterial vaginosis (BV) and the increased risk of sexually transmitted infection (STI) coinfections

In this livestream, I will discuss the Naegleria fowleri cases I'm aware of in 2026.

In this news report, I look at the concerning situation in Japan with rising syphilis cases and a penicillin shortage.

In this news episode of Outbreak News Radio, I go over the latest measles news from Pennsylvania.

In this news episode, I look at the anthrax outbreak in Mpika District, Zambia.

A quick look at the dengue situation in Hillsborough County and the rest of Florida.

Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial resistant threats to public health worldwide. Clinicians expect to be confronted by rising rates of treatment failure in the years to come. As gonorrhea rates rise and treatment options become more limited, researchers are calling for a more tailored approach that combines new diagnostics, rapid resistance testing, surveillance and additional treatment options for the sexually transmitted disease. Joining me today to discuss drug-resistant gonorrhea is Dr. Lao-Tzu Allan-Blitz, Dr Allan-Blitz is an assistant professor in UCLA's David Geffen School of Medicine's Division of Infectious Diseases in the Department of Medicine, recently co-edited a supplement in the journal Clinical Infectious Diseases that outlines the threat and highlights recent advances in diagnostics and therapeutics that can help. Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae

I look at outbreaks around the world over the past week from every continent: Ebola in DRC, malaria in DRC, Lassa in Nigeria, JE in Nepal, polio in Afghanistan, Legionnaires' disease in France, Sri Lanka dengue, Dengue in TampaBay, Florida and more.

In this news video, I go over the latest numbers from the Ebola Bundibugyo outbreak in the Democratic Republic of the Congo. In addition, I look at what some major health organizations, like MSF, WHO and Africa CDC, say about their concerns about the outbreak. Lastly, I offer some good news about some suspected cases that turned out negative very close to the capital city of Kinshasa.

Women who test positive for bacterial vaginosis (BV) were over three times more likely to also test positive for one or more non-viral sexually transmitted infections (STIs) than women who test negative for BV, according to a new Health Trends® study from Quest Diagnostics and Hologic, Inc., published in the journal Obstetrics and Gynecology Open. Joining me today to discuss the study and what healthcare providers should do based on this information is Beth Marlowe , PhD. Dr Marlowe is Executive Scientific Director and heads R&D for Quest Diagnostics Infectious Diseases and Immunology and co author of the study.   Vaginitis and Sexually Transmitted Infections Coinfections

The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments has established that the protocol is safe, causing no serious adverse events or increases in suicidal thinking or behavior.  In fact, the preliminary clinical results exceeded researchers' expectations. Joining me to discuss psilocybin-assisted therapy and PTSD and the study published in the journal Communications Medicine is Stacey Armstrong , PhD. Dr Armstrong is the Associate Director and Senior Researcher at the Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University   Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial